SD Biosensor Inc (137310) — Financial Flexibility Index
SD Biosensor Inc (137310) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of ₩27.53 Billion (operating CF ₩14.90 Billion minus capex ₩12.64 Billion) represents 0% of total liabilities (₩914.08 Billion). Check SD Biosensor Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SD Biosensor Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for SD Biosensor Inc across 6 annual periods. For the full cash flow conversion analysis, see SD Biosensor Inc cash flow conversion.
Annual Financial Flexibility Index for SD Biosensor Inc (2019–2024)
Year-by-year free cash flow to debt coverage for SD Biosensor Inc. Explore how well can SD Biosensor Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.25x | ₩237.43 Billion | ₩156.53 Billion | ₩956.18 Billion | ▲ +343.5% |
| 2023 | -0.10x | ₩-97.63 Billion | ₩-242.32 Billion | ₩957.28 Billion | ▼ -102.7% |
| 2022 | 3.78x | ₩1.19 Trillion | ₩890.23 Billion | ₩315.14 Billion | ▲ +112.6% |
| 2021 | 1.78x | ₩1.42 Trillion | ₩1.23 Trillion | ₩801.72 Billion | ▲ +127.4% |
| 2020 | 0.78x | ₩550.29 Billion | ₩495.38 Billion | ₩704.10 Billion | ▲ +326.6% |
| 2019 | 0.18x | ₩5.83 Billion | ₩-1.62 Billion | ₩31.80 Billion | — |